EZN-3920
/ Enzon
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
December 10, 2012
Targeting the HER3-phosphatidyl inositol-3 kinase pathway in breast cancers
(SABCS 2012)
- “...Luminal breast tumor xenografts treated with U3-1287, a humanized monoclonal anti-ErbB3 antibody, or EZN-3920, an anti-sense oligonucleotide against ErbB3, decreased tumor growth and phosphatidyl inositol-3 kinase (PI3K)/mTOR signaling in vivo...”
Preclinical • Breast Cancer • Oncology
1 to 1
Of
1
Go to page
1